Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) rose 5.7% on Monday after an insider bought additional shares in the company. The stock traded as high as $22.10 and last traded at $21.97. Approximately 2,810,538 shares traded hands during mid-day trading, a decline of 59% from the average daily volume of 6,811,084 shares. […]
Hims & Hers Health (NYSE:HIMS – Free Report) had its price objective hoisted by Canaccord Genuity Group from $20.00 to $24.00 in a research report sent to investors on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock. HIMS has been the topic of several other research reports. Leerink Partnrs reiterated […]
Citigroup downgraded shares of Hims & Hers Health (NYSE:HIMS – Free Report) from a buy rating to a neutral rating in a report published on Wednesday, MarketBeat.com reports. Citigroup currently has $20.00 price target on the stock, up from their previous price target of $16.00. Several other equities analysts have also issued reports on HIMS. […]
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report)’s share price gapped down before the market opened on Wednesday following insider selling activity. The stock had previously closed at $17.56, but opened at $17.11. Hims & Hers Health shares last traded at $16.71, with a volume of 1,528,158 shares traded. Specifically, insider Soleil Boughton […]
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) insider Irene Becklund sold 943 shares of the stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average price of $14.50, for a total value of $13,673.50. The transaction was disclosed in a document filed with the Securities […]